@FiercePharma: Figo launches new pet insurance plans amid booming market. FierceAnimalHealth story | Follow @FiercePharma
@EricPFierce: Lilly's Elanco unloading Novartis California vax plant it picked up in animal health deal. FiercePharmaManufacturing report | Follow @EricPFierce
@CarlyHFierce: Mylan Board Unanimously Rejects Unsolicited Expression of Interest from Teva. Release | Follow @CarlyHFierce
> Novartis ($NVS) said its blood cancer drug Arzerra hit its goal in a Phase III study in relapsed patients with chronic lymphocytic leukemia (CLL). Release
> Former Israeli President Shimon Peres has signed on as a consultant at Teva Pharmaceutical ($TEVA), planning to donate his $10,000-per-month pay to charity. Report
> A gynecological drug from Hungary-based Richter, Esmya, won a European recommendation for long-term use against uterine fibroid symptoms. Report
> The U.S. Supreme Court is set to hear arguments over a drug the state of Oklahoma used in executions after the usual injections ran scarce. Report
> Brazilian drugmaker Hypermarcas posted flat profits for the first quarter, as higher sales were offset by higher costs. Report
> Moberg Pharma bought Balmex brand over-the-counter products in the U.S. for $3.9 million. Report
Medical Device News
@FierceMedDev: ICYMI from FierceDiagnostics: Veracyte unveils $40M private placement to generate cash for R&D. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI: Updated w/ $MDT comment: Medtronic facing new wrongful death lawsuit over failed insulin pump in wake of 2009 recall. More | Follow @VarunSaxena2
@EmilyWFierce: Neuronetics raised $34.3M in a Series F round led by $GE for noninvasive magnetic stimulation device for depression. More from the WSJ | Follow @EmilyWFierce
> Sorin Group touts study showing its flexible implant for mitral valve disease is better than Medtronic's. More
> Spectranetics shares slump as the medical laser maker snips forecast. Story
> Boston Scientific loses bid to throw out claims tied to vaginal mesh device. Report
Biotech News
@FierceBiotech: Biogen partner Sobi and its Boston-based CEO field a takeover bid. News | Follow @FierceBiotech
@JohnCFierce: No, $BLUE is not $CLDN. Not hard to separate these companies' technology/pipelines. | Follow @JohnCFierce
@DamianFierce: tal im' oh jeen la her" pa rep' vek. Amgen file | Follow @DamianFierce
> FDA review challenges Amgen on a questionable T-Vec study. Story
> Synta CEO bolts after less than a year, leaving a biotech on the mend. News
> Celgene bags a build-to-buy biotech in $485M cancer deal. Report
Animal Health News
> Bayer closes MO animal health plant, citing excess capacity. News
> New study warns you can catch diseases from your pets. Story
> Lilly beats estimates on newly bulked-up animal health unit. Item
> Fallout continues in wake of avian bird flu spreading across the U.S. More
> Dog data at AACR cancer confab may point to personalized treatments. Report
Biotech IT News
> Quest, LabCorp team to build database of cancer genetics. News
> Edico and Intel set sights on real-time whole genome analysis. More
> Lilly, Novartis and Pfizer give trial-patient matching tech to TrialReach. Report
> WuXi invests $15M in DNAnexus to fuel push into China. Story
> AstraZeneca tightens ties to Roche's informatics platform provider. Article
And Finally... U.S. scientists are scrambling to gain understanding of newly emergent avian flu viruses. Report